2017 Research and Innovation Grant Recipients

2017 Research and Innovation Grant Recipients

Diagnostic Services Manitoba is pleased to announce the awardees in the 2017 Research and Innovation Grant Competition. The grants provide funding for research with a focus on knowledge translation leading to adoption and implementation of evidence- based clinical practice and patient outcome improvements.

This year, three projects received funding in the small grant category:

Creating a New Ovarian Cancer Pathology Resource for Research and Innovation in Manitoba

Principal Investigator: Dr. Mark Nachtigal (Biochemistry and Human Genetics, University of Manitoba and Senior Scientist, CancerCare Manitoba)
Co-Applicant: Dr. Cyrille Bicamumpaka (DSM/Pathology, University of Manitoba)

Project Summary:

The objective of this study is to build an ovarian cancer tissue microarray (TMA) that can be used as an innovative research tool to advance ovarian cancer research and diagnostic capabilities in Manitoba.

Scleraxis as a Biomarker for Cardiac Fibrosis in Hypertrophic Cardiomyopathy

Principal Investigator: Dr. Davindar Jassal (Radiology and Physiology, St Boniface Research Centre)

Co-Applicants: Drs. Ian Kirkpatrick (Radiology) and Michael Czubryt (Dept of Physiology, University of Manitoba)

Project Summary:

Sudden cardiac death (SCD) due to cardiovascular disease is a leading cause of death in Canada that is entirely preventable. In people younger than 40 years, hypertrophic cardiomyopathy (HCM) is a common cause of SCD. The objective of this study is to determine whether the scleraxis protein, which is a biomarker of cardiac fibrosis, is detectable and correlates with the incidence of cardiovascular disease in patients with HCM as seen in MRI images.

Prognostic Significance of Telomere Length in Follicular Lymphoma: A Population-Based Study

Principal Investigator: Dr. Michel Nasr (DSM, Pathology)

Co-Applicants: Drs. Arshad Ahsanuddin (DSM, Pathology) and Anamarija Perry (DSM, Dept of Pathology, University of Manitoba)

Project summary:

This study aims to evaluate telomere length (TL) in a group of de novo follicular lymphoma (FL) patients in Manitoba. The prognostic significance of telomere length in FL patients treated with chemotherapy, as well as the correlation of telomere length with other clinical parameters and immunohistochemical markers, will be assessed.

This entry was posted in News, Research. Bookmark the permalink. Both comments and trackbacks are currently closed.